Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel polymer micelles plus cisplatin in locally advanced head and neck squamous cell carcinoma
ChiCTR2500110591Phase 2Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital Airport Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by Tianjin Medical University Cancer Institute and Hospital Airport Hospital. Primary endpoint: Response of target lesions. Started Oct 2025; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ChiCTR2500110591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110591.